Parasitic infection – Traveler's disease
Amebiasis – Entamoeba histolytica
Amebiasis is a parasitic infection caused by the protozoan Entamoeba histolytica, transmitted fecal-orally in areas with inadequate sanitation. The third leading cause of parasitic death worldwide after malaria and schistosomiasis, it affects approximately 50 million people annually and causes 100,000 deaths per year, primarily in Southeast Asia, sub-Saharan Africa, Central America, and South America. In Quebec, amebiasis is mainly encountered in travelers returning from endemic areas, immigrants from these regions, and more rarely in certain at-risk groups. The disease can remain asymptomatic for months before manifesting as amebic colitis or, in invasive cases, amebic liver abscess.
Parasitic cycle and modes of transmission
Entamoeba histolytica exists in two distinct forms during its life cycle:
| Shape | Features | Role in infection |
|---|---|---|
| Cyst (infectious stage) | Thick-walled, tetranucleate, environmentally resistant form (survival several weeks in water and moist soil, resistance to standard water chlorination) | Ingestion by the host via contaminated water or food. It resists gastric acidity, excysts in the small intestine to release trophozoites. |
| Trophozoite (invasive vegetative form) | Mobile and active form, mononucleated, capable of phagocytosis and tissue lysis through proteolytic enzymes (cysteine proteases, ameboporin) and surface lectins | Colonizes the colon, can invade the intestinal lining creating «bottle-neck» ulcers, then migrate via the portal vein to the liver and less commonly to other organs |
The main routes of contamination are the ingestion of untreated water or contaminated ice, the consumption of raw foods (raw vegetables, unpeeled fruits, seafood) handled by unclean hands, direct oro-anal contact, and less commonly transmission by flies and cockroaches acting as mechanical vectors.
ℹ️
Entamoeba histolytica is morphologically identical to Entamoeba dispar and Entamoeba moshkovskii, two non-pathogenic species much more common (10 times more common than E. histolyticaThis microscopic resemblance has long led to an overestimation of the prevalence of pathogenic amebiasis. Only molecular biology (PCR) can reliably distinguish these species, which has direct implications for treatment decisions.
The clinical forms of amebiasis are: * **Intestinal amebiasis:** * **Asymptomatic cyst carrier:** The person harbors *Entamoeba histolytica* cysts but has no symptoms. * **Amebic dysentery:** Characterized by bloody diarrhea, abdominal pain, and fever. * **Chronic amebiasis:** Persistent or intermittent symptoms, including diarrhea, constipation, abdominal pain, and weight loss. * **Ameboma:** A granulomatous mass in the intestine, usually in the cecum or colon, which can cause obstruction. * **Extra-intestinal amebiasis:** * **Amebic liver abscess:** The most common extra-intestinal manifestation, presenting with fever, hepatomegaly, and right upper quadrant pain. * **Pulmonary amebiasis:** Metastasis to the lungs, often from a liver abscess. * **Cutaneous amebiasis:** Infection of the skin, typically around the perianal area or draining sinus tracts, often seen in immunocompromised individuals. * **Cerebral amebiasis:** Rare, but can occur with widespread disease. * **Pericardial amebiasis:** Very rare, usually secondary to an amebic liver abscess.
| Clinical form | Frequency | Introduction and Symptoms |
|---|---|---|
| Asymptomatic carriage | 80-90 % of infected people | Intestinal infection without symptoms, incidentally detected during a coproparasitology examination. The carrier excretes cysts in the stool and serves as a reservoir for transmission. Treatment recommended to eliminate carriage and prevent progression to an invasive form. |
| Non-dysenteric amebic colitis | Moderate intestinal symptomatic form | Diffuse abdominal pain or cramps, moderate non-bloody diarrhea, bloating, nausea. Can last for several weeks and be mistaken for irritable bowel syndrome or a common gastroenteritis. |
| Amebic dysentery (invasive amebic colitis) | Severe intestinal symptomatic form | Bloody and mucus-filled diarrhea («bloody-mucus stools»), intense abdominal cramps, rectal tenesmus (painful urges to defecate), moderate fever (38-39°C). Gradual onset over 1 to 3 weeks, unlike bacterial dysenteries which are often more sudden. Risk of severe dehydration, especially in children. |
| Amoebic liver abscess | Most frequent extra-intestinal complication (3-9 % of invasive forms) | Pain in the right hypochondrium radiating to the right shoulder, high fever (39-40°C) with chills, painful hepatomegaly on palpation. Concomitant intestinal symptoms are absent in 50-70 % of cases. Affects adult men preferentially (10:1 male/female ratio). Risk of rupture into the pleural, pericardial, or peritoneal cavity. |
| Rare extraintestinal amebiasis | Rare (<1 %) | Amebic lung abscess (by contiguity or hematogenous spread from the liver), amebic brain abscess (poor prognosis), cutaneous amebiasis (perianal or genital ulcers), amebic pericarditis (surgical emergency) |
Alarm signs requiring urgent consultation
Consult the emergency room without delay if you experience a high fever with pain in the right upper abdomen after traveling to a tropical area (suspected amebic liver abscess), abundant bloody diarrhea with signs of dehydration (low blood pressure, rapid pulse, confusion), diffuse and intense abdominal pain suggesting peritonitis (complication of a perforated amebic colitis), or respiratory distress with right pleural pain (pleuropulmonary rupture of a liver abscess).
How is the diagnosis established?
| Review | Utility and interpretation | Limits |
|---|---|---|
| Coprology (stool parasitological examination) | Detection of cysts or trophozoites of'Entamoeba in fresh stool. Three samples on three consecutive days increase sensitivity. Hematophagous trophozoites (containing ingested red blood cells) are characteristic of E. histolytica pathogen | Does not distinguish E. histolytica en E. dispar or E. moshkovskii |
| Fecal PCR (molecular biology) | Gold standard examination to identify and differentiate with certainty E. histolytica, E. dispar and E. moshkovskii. Superior sensitivity and specificity of over 95% %. Recommended as the diagnostic tool of choice when available. | Not available in all labs. Higher cost than conventional coproparasitology |
| Fecal antigen detection (ELISA or immunochromatography) | Rapid tests detecting specific antigens E. histolytica in stool. Sensitivity of 85-95 %, high specificity. Allows to distinguish E. histolytica of other non-pathogenic species | Availability varies by center. Possible false negatives in cases of low parasitic load. |
| Serology (antibodies against-E. histolytica) | Particularly useful for the diagnosis of amebic liver abscess, where serology is positive in 85-95 %of cases. Less useful for intestinal forms (positivity of 50-70 % ). | Remains positive for years after a resolved infection, limiting its usefulness in endemic areas where reinfections are frequent. |
| Abdominal ultrasound | First-line examination for the detection of amebic liver abscess: well-defined hypoechoic image, most often unique, in the right lobe of the liver. Allows for guided puncture if necessary and monitoring of resolution under treatment. | It does not allow for the certain differentiation between an amoebic abscess and a pyogenic bacterial abscess. Abdominal CT scans offer better characterization. |
| Rectoscopy or colonoscopy with biopsies | Direct visualization of characteristic «flask-shaped» intestinal ulcerations in amebic colitis. Biopsies can identify trophozoites in the mucosa. Indicated in cases of diagnostic doubt with inflammatory bowel disease. | To be performed with caution in case of severe colitis due to the risk of perforation. Do not confuse with Crohn's disease or ulcerative colitis before ruling out amebiasis, as corticosteroids prescribed for these diseases would worsen an unrecognized amebiasis. |
What is the treatment for amebiasis?
Treatment relies on two classes of antiparasitics with complementary mechanisms: agents active against invasive tissue forms (trophozoites) and agents active against intestinal luminal forms (cysts). Comprehensive management of both phases is essential to prevent relapses.
| Clinical situation | First-line treatment | Duration and remarks |
|---|---|---|
| Asymptomatic carriage | Paromomycin (luminal agent only): 25-35 mg/kg/day in 3 divided doses | 7 days. Eliminates intestinal cysts with no significant systemic absorption. Treatment recommended even without symptoms to eliminate carriage and prevent transmission and progression to an invasive form. |
| Symptomatic amebic colitis | Metronidazole (tissue agent): 500-750 mg three times a day, followed by paromomycin to eradicate residual luminal forms. | Metronidazole for 7 to 10 days, then paromomycin for 7 days. Do not omit the luminal phase: metronidazole alone is not sufficient to eliminate intestinal cysts, exposing to a high risk of relapse. |
| Amoebic liver abscess | High-dose metronidazole: 750 mg three times a day, followed by paromomycin. Tinidazole is an effective alternative with better gastrointestinal tolerance and simplified dosing (2 g/day). | Metronidazole for 10 days. Clinical resolution expected within 72 hours. Radiological regression of the abscess is slower (weeks to months) and should not dictate discontinuation of treatment if the clinical course is favorable. |
| Liver abscess drainage | Percutaneous ultrasound- or CT-guided aspiration-biopsy, as a complement to drug therapy | Indicated if: large abscess (>5 cm), imminent risk of rupture, absence of clinical response to medical treatment after 72 hours, left lobe abscess (risk of pericardial rupture). Not systematic for small abscesses responding well to medical treatment. |
| Severe forms or intolerance to oral metronidazole | Intravenous metronidazole in a hospital setting, or oral tinidazole as an alternative | Hospitalization recommended for severe forms, complications (peritonitis, pleuropulmonary rupture), or immunocompromised patients. |
ℹ️
Metronidazole interacts with alcohol, causing an antabuse effect (nausea, vomiting, flushing, tachycardia). Complete abstinence from alcohol is mandatory during treatment and for 48 hours after the last dose. Metronidazole can also potentiate the effect of oral anticoagulants. INR monitoring is recommended in patients taking warfarin.
Prevention during travel in endemic areas
- Golden rule «boil it, cook it, peel it, or forget it»: only consume capped bottled or boiled water (open bottled mineral water and ice cubes are frequent sources of contamination), avoid raw vegetables, salads, and unpeeled fruits, favor food served hot and freshly cooked.
- Thorough hand washing with soap and water before meals and after using the toilet. Hand sanitizer alone does not destroy cysts of'E. histolytica Physical washing with friction is essential
- Avoid brushing your teeth with tap water in at-risk areas, use only bottled water for oral hygiene.
- Do not consume fresh fruit juices prepared with local water, smoothies, or drinks with ice cubes in establishments with questionable hygiene.
- Chlorine-based water purification tablets reduce the risk of bacterial contamination but are insufficient on their own against protozoan cysts: boiling for 1 minute (3 minutes at altitude) remains the most reliable method, or the use of membrane filters of 1 micron or less
- Consult a travel medicine doctor before any departure to tropical or subtropical areas for a health check-up and personalized advice tailored to the destination and type of travel.
How to distinguish amebiasis from other causes of traveler's diarrhea?
| Features | Amebiasis (amebic colitis) | Shigellosis (bacterial dysentery) | Giardiasis |
|---|---|---|---|
| Start | Progressive, 1 to 3 weeks | Brutal, 1 to 3 days | Progressive, 1 to 3 weeks |
| In this | Bloody, not voluminous, frequent | Bloody, purulent, very frequent | Greasy, smelly, bulky, non-bloody |
| Fever | Moderate (38-39°C) or absent | High (39-40°C), with chills | Absent or very discreet |
| Abdominal pain | Cramps, tenesmus | Intense cramps, marked tenesmus | Bloating, flatulence, epigastric discomfort |
| Extraintestinal complication | Amebic liver abscess (weeks to months after) | Hemolytic uremic syndrome (rare, especially E. coli O157) | Chronic malabsorption if left untreated |
| Treatment | Metronidazole then paromomycin | Azithromycin or fluoroquinolone | Metronidazole or tinidazole |
Consult at Clinique Omicron
If you are returning from a trip to a tropical region and experience persistent digestive symptoms (diarrhea, cramps, blood in stool), fever with pain under the right rib cage, or if you wish to have a post-travel parasitic examination, the doctors at Clinique Omicron, at their service points in Quebec, can perform the clinical evaluation, prescribe the appropriate parasitic tests, and initiate the suitable antiparasitic treatment. The clinic also offers travel medicine consultations for individuals planning a stay in an endemic area.
The content of this page is provided for informational purposes only and is not intended to replace the advice of a qualified healthcare professional. Consult a physician for any symptoms, questions or decisions you may have regarding your health.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.